Source:http://linkedlifedata.com/resource/pubmed/id/18287296
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Pt 3
|
pubmed:dateCreated |
2008-2-21
|
pubmed:databankReference | |
pubmed:abstractText |
An imipenem-resistant isolate of Citrobacter freundii ZJ163 (MIC 256 microg ml(-1)) isolated from a Chinese hospital was investigated. The C. freundii ZJ163 isolate exhibited high-level resistance to carbapenems, penicillins, cephalosporins, cefoxitin, aztreonam, quinolones and aminoglycosides. Isoelectric focusing (IEF) demonstrated three beta-lactamases with pIs of 5.4 (TEM-1), 6.7 (KPC-2) and 7.9 (CTX-M-14). Two different transconjugants (types A and B) were obtained by conjugation studies. The type A transconjugant exhibited reduced susceptibility or resistance to penicillins, cephalosporins and aztreonam, but was susceptible to carbapenems, quinolones and aminoglycosides. The antimicrobial susceptibility patterns of the type B transconjugant were similar to that of type A, except for its significantly reduced carbapenem susceptibility (imipenem MIC 2 microg ml(-1)). IEF, specific PCRs and DNA sequence analysis indicated that the type A transconjugant produced CTX-M-14 beta-lactamase with a pI of 7.9, that the type B transconjugant produced KPC-2 beta-lactamase with a pI of 6.7 and that the beta-lactamase with a pI of 5.4 was TEM-1. PCR analysis and sequencing confirmed the presence of the ampC gene in the chromosomal DNA from C. freundii ZJ163, although no activity of AmpC beta-lactamase was detected by IEF. Urea/SDS-PAGE analysis of outer-membrane proteins revealed that the levels of the 41 and 38 kDa porins were decreased in C. freundii ZJ163. It was concluded that production of KPC-2 combined with decreased expression of porins contributes to high-level resistance to carbapenems in C. freundii ZJ163.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Carbapenems,
http://linkedlifedata.com/resource/pubmed/chemical/Imipenem,
http://linkedlifedata.com/resource/pubmed/chemical/Porins,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Lactamases,
http://linkedlifedata.com/resource/pubmed/chemical/beta-lactamase KPC-2
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-2615
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
332-7
|
pubmed:meshHeading |
pubmed-meshheading:18287296-Anti-Bacterial Agents,
pubmed-meshheading:18287296-Carbapenems,
pubmed-meshheading:18287296-Citrobacter freundii,
pubmed-meshheading:18287296-Conjugation, Genetic,
pubmed-meshheading:18287296-Drug Resistance, Bacterial,
pubmed-meshheading:18287296-Humans,
pubmed-meshheading:18287296-Imipenem,
pubmed-meshheading:18287296-Microbial Sensitivity Tests,
pubmed-meshheading:18287296-Molecular Sequence Data,
pubmed-meshheading:18287296-Plasmids,
pubmed-meshheading:18287296-Polymerase Chain Reaction,
pubmed-meshheading:18287296-Porins,
pubmed-meshheading:18287296-Sequence Analysis, DNA,
pubmed-meshheading:18287296-beta-Lactamases
|
pubmed:year |
2008
|
pubmed:articleTitle |
High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression.
|
pubmed:affiliation |
Second Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, PR China.
|
pubmed:publicationType |
Journal Article
|